Delivery Order SPE2DR25D2104-SPE2DR26F3NZC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,734.12 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count). This competitively awarded, firm fixed-price contract carries an ultimate completion date of November 5, 2025, and represents a small-value pharmaceutical procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order was issued without any set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $51,571.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 (60-count units), a combination inhalation medication used in respiratory disease management. This firm fixed price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,758.08 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count supply) on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award...
- The Defense Logistics Agency awarded a delivery order valued at $3,753.67 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used in respiratory disease management. The contract is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $7,508.38 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (a combination respiratory medication), with an ultimate completion date of November 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,331.47 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 (60-count inhalers), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This non-competitive delivery order, issued on November 10, 2025, with completion expected by November 12, 2025, represents a firm fixed-price pharmaceutical supply transaction. The award was fulfilled from AmerisourceBergen's place of performance in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 (a combination respiratory medication) in the amount of $9,582.39 with an ultimate completion date of September 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,492.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $1,251.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used in respiratory disease treatment. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,347.03 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This non-competitive, firm fixed-price delivery order is set to be completed by October 28, 2025, with performance taking place at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The order represents a small-value...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NZCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,173.80 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation medication used in respiratory disease management. The contract is firm fixed price with no set-aside designation, indicating it was competitively awarded. Performance is to be completed by November 14, 2025, with the product delivered to Conshohocken, Pennsylvania, the vendor's corporate headquarters location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and Defense Health Agency operations worldwide. The current delivery order represents a routine pharmaceutical procurement within this established contract relationship, leveraging AmerisourceBergen's position as a major pharmaceutical distributor with demonstrated federal contracting capability across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 11/13/25 |